Skip to content

Menopause Health Center

Font Size

Low-Dose Estrogen Patch Gets FDA Nod

Menostar Patch Approved for Osteoporosis Prevention
WebMD Health News

June 10, 2004 -- Menostar Patch, a very-low-dose estrogen patch, is now FDA approved for prevention of bone loss in postmenopausal women.

Estrogen replacement therapy is controversial these days. But there's no argument about one effect of the female hormone. It's good for preventing bone loss due to osteoporosis.

Hormone therapy, doctors agree, should be used at the lowest possible dose for the shortest possible time. Menostar Patch has the low-dose angle covered. The dime-sized, once-a-week patch delivers just half the estrogen of the lowest-dose estrogen patch now available.

Estrogen therapy usually has to be balanced with another hormone, progestin, to lower the risk of uterine cancer. Many experts believe that most of the risk from hormone therapy comes from the progestin component. But Menostar Patch offers such a low estrogen dose that no progestin is needed.

This dose is expected to give most women just enough estrogen to prevent bone loss. In clinical trials, two years of Menostar Patch therapy helped postmenopausal women increase bone density.

Menostar Patch is made by Berlex Inc., the U.S. affiliate of German drug giant Schering AG.

Today on WebMD

woman walking outdoors
How to handle headaches, night sweats, and more.
mature woman holding fan in face
Symptoms and treatments.
woman hiding face behind hands
11 ways to keep skin bright and healthy.
Is it menopause or something else?
senior couple
mature woman shopping for produce
Alcohol Disrupting Your Sleep
mature couple on boat
mature woman tugging on her loose skin
senior woman wearing green hat
estrogen gene